Trials / Completed
CompletedNCT01269541
MESS-study MRSA Eradication Study Skåne
MESS- MRSA Eradication Study Skåne. A Comparison Between Systemic Antibiotic Treatment in Combination With Topical Mupirocintreatment With Only Topical Mupiroicintreatment to Eradicate MRSA in Throat Carriers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether systemic antibiotic treatment with rifampicin and clindamycine or trimethoprim-sulfa in addition to topical treatment with mupirocin is more effective than only topical treatment to eradicate MRSA in throatcarriers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mupirocin | Topical in the nose 3 times daily for 5 days |
| DRUG | Rifampin+Clindamycine or Trimehoprimsulfa | Rifampicin 10 mg/kgx1xVII Clindamycine 300 mgx3 Trimethoprimsulfa 400mg/80mg 2x2 |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2011-01-04
- Last updated
- 2017-08-22
Locations
6 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01269541. Inclusion in this directory is not an endorsement.